| 摘要 |
PROBLEM TO BE SOLVED: To obtain a prophylactic and a therapeutic agent for JNK-associated pathological condition or disorder that exhibits excellent JNK-specific inhibitory activity and excellent oral absorption. SOLUTION: The compound is represented by formula (ring A and ring B are each a benzene ring which may be substituted; the substituent group, which each of the ring A and the ring B may contain, is, for example, a halogen atom, a cyano group, a nitro group, a hydrocarbon group which may be substituted, a heterocyclic group which may be substituted, a hydroxy group which may be substituted, a thiol group which may be substituted, a substituted sulfinyl group, a substituted sulfonyl group, an acyl group, an amino group which may be substituted, a carbamoyl group which may be substituted, a carboxy group which may be esterified or the like) or its salt. COPYRIGHT: (C)2006,JPO&NCIPI
|
